User menu

Guillain-Barré syndrome associated with Puumula Hantavirus infection.

Bibliographic reference Tassart, G ; Balbeur, S ; Deltombe, Thierry ; Tintillier, M ; Cuvelier, Ch. Guillain-Barré syndrome associated with Puumula Hantavirus infection.. In: Acta Clinica Belgica, Vol. 69, no. 5, p. 371-374 (2014)
Permanent URL http://hdl.handle.net/2078.1/151472
  1. FORSLUND T., SALTEVO J., ANTTINEN J., AUVINEN S., BRUMMER-KORVENKONTIO M., KORHONEN A., POUTIAINEN M., Complications of nephropathia epidemica: three cases, 10.1111/j.1365-2796.1992.tb00555.x
  2. Esselink R.A.J, Gerding M.N, Brouwers P.J.A.M, Solleveld H, Jordans J.G.M, Groen J, Osterhaus A.D.M.E, Guillain-Barré syndrome associated with hantavirus infection, 10.1016/s0140-6736(94)90975-x
  3. Rabaud C., May T., Hoen B., Maignan M., Gerard A., Canton P., Guillain-Barre Syndrome Associated with Hantavirus Infection, 10.1093/clinids/20.2.477
  4. Hughes Richard A. C., Rees Jeremy H., Clinical and Epidemiologic Features of Guillain‐Barré Syndrome, 10.1086/513793
  5. Rees Jeremy H., Soudain Sara E., Gregson Norman A., Hughes Richard A.C., Campylobacter jejuniInfection and Guillain–Barré Syndrome, 10.1056/nejm199511233332102
  6. Hahn Angelika F, Guillain-Barré syndrome, 10.1016/s0140-6736(97)12308-x
  7. Hadden R.D.M., Karch H., Hartung H.-P., Zielasek J., Weissbrich B., Schubert J., Weishaupt A., Cornblath D.R., Swan A.V., Hughes R.A.C., Toyka K.V., Preceding infections, immune factors, and outcome in Guillain-Barre syndrome, 10.1212/wnl.56.6.758
  8. Jacobs B. C., Rothbarth P. H., van der Meche F.G.A., Herbrink P., Schmitz P. I.M., de Klerk M. A., van Doorn P. A., The spectrum of antecedent infections in Guillain-Barre syndrome: A case-control study, 10.1212/wnl.51.4.1110
  9. Kang Jiunn‐Horng, Sheu Jau‐Jiuan, Lin Herng‐Ching, Increased Risk of Guillain‐Barré Syndrome following Recent Herpes Zoster: A Population‐Based Study across Taiwan, 10.1086/655136
  10. Lehmann Helmar C, Hartung Hans-Peter, Kieseier Bernd C, Hughes Richard AC, Guillain-Barré syndrome after exposure to influenza virus, 10.1016/s1473-3099(10)70140-7
  11. Asbury Arthur K., Cornblath David R., Assessment of current diagnostic criteria for Guillain-Barr� syndrome, 10.1002/ana.410270707
  12. Vriesendorp FJ, Shefner JM, Targoff IN, Dashe JF. Clinical features and diagnosis of Guillain-Barré syndrome in adults. Available from: http://www.uptodate.com/contents/clinical-features-and-diagnosis-of-guillain-barre-syndrome-in-adults?source = search_result&search = guillain+barre+syndrome+adult&selectedTitle = 1∼150 (accessed December 2013).
  13. Hughes R. A. C., Swan A. V., Raphael J.-C., Annane D., van Koningsveld R., van Doorn P. A., Immunotherapy for Guillain-Barre syndrome: a systematic review, 10.1093/brain/awm004
  14. Young Nathan, Weinshenker Brian, Lucchinetti Claudia, Acute Disseminated Encephalomyelitis: Current Understanding and Controversies, 10.1055/s-2007-1019130
  15. Toivanen A.-L., Valanne L., Tatlisumak T., Acute disseminated encephalomyelitis following nephropathia epidemica, 10.1034/j.1600-0404.2002.1c168.x
  16. Krause Robert, Aberle Stephen, Haberl Renate, Daxböck Florian, Wenisch Christoph, Puumala Virus Infection with Acute Disseminated Encephalomyelitis and Multiorgan Failure, 10.3201/eid0905.020405
  17. Huisa Branko N, Chapin John E, Adair John C, Central nervous system complications following Hanta virus cardiopulmonary syndrome, 10.1080/13550280802491485
  18. Marchioni E., Ravaglia S., Piccolo G., Furione M., Zardini E., Franciotta D., Alfonsi E., Minoli L., Romani A., Todeschini A., Uggetti C., Tavazzi E., Ceroni M., Postinfectious inflammatory disorders: Subgroups based on prospective follow-up, 10.1212/01.wnl.0000179302.93960.ad
  19. Hughes Richard A. C., Wijdicks Eelco F. M., Benson Estelle, Cornblath David R., Hahn Angelika F., Meythaler Jay M., Sladky John T., Barohn Richard J., Stevens James C., Supportive Care for Patients With Guillain-Barré Syndrome, 10.1001/archneur.62.8.1194
  20. Chio A., Cocito D., Leone M., Giordana M.T., Mora G., Mutani R., , Guillain-Barre syndrome: A prospective, population-based incidence and outcome survey, 10.1212/01.wnl.0000055091.96905.d0
  21. Randomised trial of plasma exchange, intravenous immunoglobulin, and combined treatments in Guillain-Barré syndrome, 10.1016/s0140-6736(96)09095-2
  22. , Plasmapheresis and acute Guillain-Barre syndrome, 10.1212/wnl.35.8.1096
  23. van der Meché F.G.A., Schmitz P.I.M., A Randomized Trial Comparing Intravenous Immune Globulin and Plasma Exchange in Guillain-Barré Syndrome, 10.1056/nejm199204233261705
  24. Guillain-Barré Syndrome Steroid Trial Group, Lancet., 341, 586 (1993)
  25. Vriesendorp FJ, Shefner JM, Dashe JF. Treatment and prognosis of Guillain-Barré syndrome in adults. Available from: http://www.uptodate.com/contents/treatment-and-prognosis-of-guillain-barre-syndrome-in-adults?source = search_result&search = guillain+barre+syndrome+adult&selectedTitle = 2∼150 (accessed December 2013).
  26. Ropper AH, Guillain-Barré syndrome (1991)